X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4049) 4049
Book Review (396) 396
Publication (282) 282
Conference Proceeding (11) 11
Book Chapter (10) 10
Book / eBook (6) 6
Dissertation (5) 5
Web Resource (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3524) 3524
humans (2156) 2156
gentamicin (2045) 2045
animals (1454) 1454
male (1425) 1425
female (1299) 1299
pharmacology & pharmacy (1220) 1220
gentamicins - pharmacokinetics (1165) 1165
gentamicins - administration & dosage (1085) 1085
pharmacokinetics (1012) 1012
anti-bacterial agents - pharmacokinetics (956) 956
anti-bacterial agents - administration & dosage (897) 897
aminoglycosides (715) 715
adult (693) 693
middle aged (645) 645
antibiotics (620) 620
aged (550) 550
microbiology (509) 509
gentamicins - blood (499) 499
gentamicins - therapeutic use (489) 489
anti-bacterial agents - therapeutic use (448) 448
rats (428) 428
kinetics (404) 404
microbial sensitivity tests (387) 387
gentamicins - pharmacology (364) 364
anti-bacterial agents - pharmacology (355) 355
half-life (344) 344
infectious diseases (341) 341
drug administration schedule (340) 340
therapy (337) 337
abridged index medicus (332) 332
nephrotoxicity (328) 328
infant, newborn (314) 314
tobramycin (309) 309
gentamicins - metabolism (302) 302
adolescent (298) 298
dose-response relationship, drug (298) 298
vancomycin (296) 296
time factors (292) 292
rabbits (284) 284
anti-bacterial agents - blood (276) 276
infections (260) 260
veterinary sciences (260) 260
amikacin (259) 259
models, biological (242) 242
anti-bacterial agents - adverse effects (238) 238
prospective studies (232) 232
aged, 80 and over (229) 229
gentamicins - adverse effects (221) 221
kidney - drug effects (221) 221
bacterial infections - drug therapy (210) 210
mice (205) 205
treatment outcome (205) 205
analysis (202) 202
pediatrics (199) 199
surgery (197) 197
gentamicins - toxicity (195) 195
child (194) 194
creatinine - blood (191) 191
infection (189) 189
toxicity (186) 186
retrospective studies (181) 181
pharmacology (179) 179
aminoglycoside antibiotics (177) 177
kidney - metabolism (175) 175
injections, intravenous (173) 173
health aspects (172) 172
metabolic clearance rate (172) 172
otorhinolaryngology (172) 172
toxicology (169) 169
drug delivery systems (168) 168
efficacy (166) 166
ototoxicity (158) 158
infant (156) 156
drugs (155) 155
in-vitro (154) 154
tobramycin - administration & dosage (151) 151
infants (150) 150
tobramycin - pharmacokinetics (150) 150
drug therapy (146) 146
tissue distribution (146) 146
drug therapy, combination (144) 144
infusions, intravenous (136) 136
staphylococcus aureus - drug effects (135) 135
aminoglycoside (134) 134
child, preschool (134) 134
children (132) 132
orthopedics (132) 132
vancomycin - pharmacokinetics (132) 132
dosage and administration (130) 130
bacteria (128) 128
disease models, animal (128) 128
medicine & public health (128) 128
amikacin - pharmacokinetics (126) 126
netilmicin (126) 126
research (126) 126
dosage (125) 125
kidney diseases - chemically induced (124) 124
urology & nephrology (122) 122
population pharmacokinetics (120) 120
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3775) 3775
German (61) 61
Russian (61) 61
Japanese (48) 48
French (46) 46
Chinese (21) 21
Polish (15) 15
Spanish (14) 14
Czech (7) 7
Italian (5) 5
Dutch (3) 3
Hungarian (3) 3
Bulgarian (2) 2
Danish (2) 2
Hebrew (2) 2
Serbian (2) 2
Slovak (2) 2
Turkish (2) 2
Croatian (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2011, Volume 55, Issue 10, pp. 4619 - 4630
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
VITRO DYNAMIC-MODEL | STREPTOCOCCUS-PNEUMONIAE | PHARMACODYNAMIC MODEL | POPULATION PHARMACOKINETICS | PSEUDOMONAS-AERUGINOSA | ADAPTIVE RESISTANCE | IN-VIVO | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MONTE-CARLO SIMULATIONS | AMINOGLYCOSIDE ANTIBIOTICS | RESPIRATORY-TRACT INFECTIONS | Fluoroquinolones | Aza Compounds - pharmacokinetics | Area Under Curve | Erythromycin - pharmacology | Escherichia coli - drug effects | Humans | Cefuroxime - pharmacology | Aza Compounds - pharmacology | Quinolines - pharmacology | Microbial Sensitivity Tests | Quinolines - pharmacokinetics | Anti-Bacterial Agents - therapeutic use | Gentamicins - pharmacology | Computer Simulation | Vancomycin - pharmacology | Streptococcus pyogenes - drug effects | Gentamicins - pharmacokinetics | Penicillin G - pharmacology | Erythromycin - pharmacokinetics | Cefuroxime - pharmacokinetics | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Penicillin G - pharmacokinetics | Index Medicus | Drugs | Subpopulations | Pharmacodynamics | Gentamicin | Benzylpenicillin | Erythromycin | Moxifloxacin | Regression analysis | Vancomycin | Drug development | Cefuroxime | Antibiotics | Minimum inhibitory concentration | Models | Pharmacokinetics | Experimental Therapeutics
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 10/2006, Volume 33, Issue 10, pp. 917 - 924
SUMMARY • Non-steroidal anti-inflammatory drugs (NSAIDs) cause renal side-effects. In the present study, we tested the hypothesis that the extent of the renal... 
pharmacokinetics | kidney | non-steroidal anti-inflammatory drugs | cyclo-oxygenase-2 | sodium urinary excretion | cyclo‐oxygenase‐2 | non‐steroidal anti‐inflammatory drugs | Cyclo-oxygenase-2 | Pharmacokinetics | Kidney | Non-steroidal anti-inflammatory drugs | Sodium urinary excretion | GASTROINTESTINAL TOXICITY | PHYSIOLOGY | CYCLOOXYGENASE-2 | RAT | HYPERKALEMIA | PROTEIN-BINDING | MELOXICAM | INTERSPECIES DIFFERENCES | GENTAMICIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY & PHARMACY | Thiazoles - blood | Area Under Curve | Thiazines - administration & dosage | Thiazines - adverse effects | Sulfones - adverse effects | Male | Thiazoles - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - blood | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Dose-Response Relationship, Drug | Cyclooxygenase 2 Inhibitors - adverse effects | Sulfonamides - blood | Lactones - blood | Lactones - pharmacokinetics | Sodium - urine | Lactones - administration & dosage | Pyrazoles - blood | Pyrazoles - pharmacokinetics | Sulfones - blood | Placebos - administration & dosage | Pyrazoles - adverse effects | Thiazines - pharmacokinetics | Kidney - drug effects | Administration, Oral | Cyclooxygenase 2 Inhibitors - administration & dosage | Rats | Thiazines - blood | Celecoxib | Lactones - adverse effects | Placebos - pharmacokinetics | Sulfones - pharmacokinetics | Cyclooxygenase 2 Inhibitors - pharmacokinetics | Rats, Sprague-Dawley | Sulfonamides - pharmacokinetics | Pyrazoles - administration & dosage | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Potassium - urine | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Sulfonamides - adverse effects | Sulfonamides - administration & dosage | Sulfones - administration & dosage | Kidney, drug effects | Lactones, adverse effects | Sulfones, administration and dosage | Thiazoles, administration and dosage | Anti-Inflammatory Agents, Non-Steroidal, pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal, adverse effects | Sodium, urine | Thiazines, blood | Anti-Inflammatory Agents, Non-Steroidal, blood | Lactones, administration and dosage | Cyclooxygenase 2 Inhibitors, adverse effects | Pyrazoles, blood | Sulfonamides, pharmacokinetics | Thiazines, pharmacokinetics | Pyrazoles, administration and dosage | Thiazoles, blood | Sulfonamides, administration and dosage | Cyclooxygenase 2 Inhibitors, administration and dosage | Lactones, pharmacokinetics | Sulfonamides, blood | Cyclooxygenase 2 Inhibitors, pharmacokinetics | Thiazines, adverse effects | Lactones, blood | Thiazoles, adverse effects | Thiazoles, pharmacokinetics | Sulfones, blood | Sulfonamides, adverse effects | Thiazines, administration and dosage | Placebos, pharmacokinetics | Sulfones, pharmacokinetics | Pyrazoles, adverse effects | Placebos, administration and dosage | Potassium, urine | Sulfones, adverse effects | Pyrazoles, pharmacokinetics | Index Medicus
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 06/2009, Volume 48, Issue 4, pp. 253 - 263
Journal Article
Critical Care, ISSN 1364-8535, 12/2015, Volume 19, Issue 1, pp. 437 - 437
Introduction: Ex vivo experiments in extracorporeal membrane oxygenation (ECMO) circuits have identified octanol-water partition coefficient (logP, a marker of... 
ECMO | SEQUESTRATION | MATCHED COHORT | DRUG-THERAPY | LIFE-SUPPORT | VENTILATION | DISEASE | ADULTS | PROTEIN-BINDING | CIRCUIT | CRITICAL CARE MEDICINE | Echinocandins - chemistry | Fluconazole - chemistry | Echinocandins - pharmacokinetics | Thienamycins - pharmacokinetics | Ceftriaxone - chemistry | Carbapenems - pharmacokinetics | Sheep, Domestic - metabolism | Thienamycins - chemistry | Vancomycin - chemistry | Carbapenems - chemistry | Anti-Infective Agents - chemistry | Extracorporeal Membrane Oxygenation - utilization | Gentamicins - chemistry | Models, Theoretical | Sheep, Domestic - physiology | Ciprofloxacin - pharmacokinetics | Gentamicins - pharmacokinetics | Ceftriaxone - pharmacokinetics | Fluconazole - pharmacokinetics | Animals | Extracorporeal Membrane Oxygenation - mortality | Vancomycin - pharmacokinetics | Anti-Infective Agents - pharmacokinetics | Ciprofloxacin - chemistry | Critical Illness - therapy | Sheep | Lipopeptides | Acute respiratory distress syndrome | Usage | Antibiotics | Fluconazole | Analysis | Research | Ciprofloxacin | Chromatography | Blood proteins | Protein binding | Respiratory therapy | Ventilators | Medical research | Intensive care | Patients | Proteins | Scholarships & fellowships | Respiratory distress syndrome | Hernias | Sepsis | Renal replacement therapy | Drug therapy | Drug dosages | Index Medicus
Journal Article
Journal Article
Bone and Joint Research, ISSN 2046-3758, 2016, Volume 5, Issue 9, pp. 427 - 435
Deep bone and joint infections (DBJI) are directly intertwined with health, demographic change towards an elderly population, and wellbeing.The elderly human... 
Infection | Prevention | Bone graft substitute | Antibiotics | Gentamicin
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 11/2018, Volume 38, Issue 11, pp. 1120 - 1129
Journal Article